NASDAQ Global Select • Healthcare • Biotechnology • US • USD
Alaunos Therapeutics, Inc. (TCRT) has a consensus analyst rating of Hold, based on 10 analysts covering the stock. Of those, 1 recommend buying, 8 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
